High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer
出版年份 2021 全文链接
标题
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 3, Pages e001965
出版商
BMJ
发表日期
2021-03-26
DOI
10.1136/jitc-2020-001965
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adenosine signalling is prognostic for cancer outcome and has predictive utility for immunotherapeutic response
- (2020) Ben Sidders et al. CLINICAL CANCER RESEARCH
- Myo1e modulates the recruitment of activated B cells to inguinal lymph nodes
- (2020) Daniel A. Girón-Pérez et al. JOURNAL OF CELL SCIENCE
- Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
- (2020) Eleni Maniati et al. Cell Reports
- Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
- (2020) Anniina Färkkilä et al. Nature Communications
- Sensing of ATP via the Purinergic Receptor P2RX7 Promotes CD8+ Trm Cell Generation by Enhancing Their Sensitivity to the Cytokine TGF-β
- (2020) Henrique Borges da Silva et al. IMMUNITY
- Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis
- (2020) Marta Vuerich et al. JOURNAL OF HEPATOLOGY
- Publisher Correction: The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- Antitumor Activity and Safety of Pembrolizumab in Patients with Advanced Recurrent Ovarian Cancer: Results from the Phase 2 KEYNOTE-100 Study
- (2019) U A Matulonis et al. ANNALS OF ONCOLOGY
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature
- (2019) Deena M. A. Gendoo et al. Scientific Reports
- Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
- (2019) Panagiotis A. Konstantinopoulos et al. JAMA Oncology
- Immunotherapy in Ovarian Cancer: Are We There Yet?
- (2019) Lana E. Kandalaft et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies
- (2019) Aung Naing et al. Journal for ImmunoTherapy of Cancer
- Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
- (2018) Cécile Le Page et al. BMC CANCER
- Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T Cell Receptors in High-riskMYCN-not-amplified Human Neuroblastoma
- (2018) Jun S. Wei et al. CLINICAL CANCER RESEARCH
- Consensus on Molecular Subtypes of High-grade Serous Ovarian Carcinoma
- (2018) Gregory M Chen et al. CLINICAL CANCER RESEARCH
- Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
- (2018) Thomas Duhen et al. Nature Communications
- CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
- (2018) Michela Lupia et al. Stem Cell Reports
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
- (2018) Ankur Chakravarthy et al. Nature Communications
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
- (2016) Arabella Young et al. CANCER CELL
- The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27
- (2016) Sènan M. d’Almeida et al. OncoImmunology
- Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
- (2016) Itsaso Montalbán del Barrio et al. Journal for ImmunoTherapy of Cancer
- Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer
- (2015) Deena M. A. Gendoo et al. BIOINFORMATICS
- CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
- (2015) Martin Turcotte et al. CANCER RESEARCH
- Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
- (2015) Jessica L. Bowser et al. JOURNAL OF CLINICAL INVESTIGATION
- A Systems Oncology Approach Identifies NT5E as a Key Metabolic Regulator in Tumor Cells and Modulator of Platinum Sensitivity
- (2015) Ekaterina Nevedomskaya et al. JOURNAL OF PROTEOME RESEARCH
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
- (2015) J. R. Webb et al. Cancer Immunology Research
- Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
- (2013) B. Allard et al. CLINICAL CANCER RESEARCH
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Removing Batch Effects From Histopathological Images for Enhanced Cancer Diagnosis
- (2013) Sonal Kothari et al. IEEE Journal of Biomedical and Health Informatics
- Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration
- (2012) Hoon Kyu Oh et al. Journal of Gynecologic Oncology
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
- (2011) Long Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now